Galera Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying

2/27/24 7:10:25 AM ET

Major Banks

Finance

Metal Mining

Basic Materials

Get the next $ASRV alert in real time by email

The Dow Jones index closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

AmeriServ Financial

The Trade: AmeriServ Financial, Inc. (NASDAQ:ASRV) Director Richard W. Bloomingdale acquired a total of 1,783 shares an average price of $2.85. To acquire these shares, it cost around $5,086.
What’s Happening: On Jan. 23, AmeriServ Financial posted a loss for the fourth quarter.
What AmeriServ Financial Does: AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services.

Dakota Gold

The Trade: Dakota Gold Corp. (NYSE:DC) Director Alice D. Schroeder acquired a total of 7,410 shares at at an average price of $1.96. To acquire these shares, it cost around $14,521.
What’s Happening: On Feb. 21, Dakota Gold announced additional results for twelve drill holes from the Richmond Hill Gold Project.
What Dakota Gold Does: Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 40 thousand acres surrounding the historic Homestake Mine.

Check This Out: Macy's, Lowe's And 3 Stocks To Watch Heading Into Tuesday

Galera Therapeutics

The Trade: Galera Therapeutics, Inc. (NASDAQ:GRTX) 10% owner Yair Schneid acquired a total of 932,402 shares at an average price of $0.18. The insider spent around $166,417 to buy those shares.
What’s Happening: On Nov. 14, Galera Therapeutics posted a narrower-than-expected third-quarter loss.
What Galera Therapeutics Does: Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

Don’t forget to check out our premarket coverage here

Get the next $ASRV alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$ASRV
$DC
$GRTX

Company	Date	Price Target	Rating	Analyst
Dakota Gold Corp. $DC	2/24/2026	$10.00	Sector Outperform	Scotiabank
Dakota Gold Corp. $DC	1/5/2026	$9.75	Buy	H.C. Wainwright
Dakota Gold Corp. $DC	9/6/2024	$6.00	Outperform	BMO Capital Markets
Galera Therapeutics Inc. $GRTX	8/10/2023	$6.00 → $0.50	Overweight → Neutral	Piper Sandler
Dakota Gold Corp. $DC	9/12/2022	$5.25	Speculative Buy	Canaccord Genuity
Galera Therapeutics Inc. $GRTX	12/20/2021	$11.00 → $20.00	Buy	Citigroup
Galera Therapeutics Inc. $GRTX	12/15/2021	$10.00	Neutral → Buy	HC Wainwright & Co.
Galera Therapeutics Inc. $GRTX	12/15/2021	$15.00	Neutral → Buy	BTIG

More analyst ratings

$ASRV
$DC
$GRTX
Press Releases

Fastest customizable press release news feed in the world

Dakota Gold Announces Appointment of Brian G. Iverson to Board of Directors

Lead, South Dakota--(Newsfile Corp. - February 27, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") is pleased to announce the appointment of Brian G. Iverson to its Board of Directors ("Board"), effective immediately. Mr. Iverson brings more than three decades of strategic leadership experience across legal, financial, regulatory, and corporate governance functions for South Dakotan companies. Mr. Iverson's local and professional experience compliment the Company's Board as Dakota Gold advances its exploration and development initiatives in South Dakota's historic Homestake District.Mr. Iverson currently serves as General Counsel and Senior Vice President Regulatory and

2/27/26 6:30:00 AM ET

Electric Utilities: Central

Utilities

Metal Mining

Basic Materials

Dakota Gold Announces Pricing of $75 Million Public Offering

Lead, South Dakota--(Newsfile Corp. - February 9, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") today announced the pricing of its previously announced public offering of 12,336,000 shares of its common stock, par value $0.001 (the "Common Stock") in the United States (the "Offering"). The Offering is expected to close on or about February 11, 2026 and is subject to the satisfaction of customary closing conditions. The gross proceeds to Dakota Gold from the Offering, before deducting expenses, will be approximately $75 million, or approximately $86.25 million if the Underwriters exercise the Option (as defined below) in full.The Company expects to use the net proceeds

2/9/26 9:53:00 PM ET

Metal Mining

Basic Materials

Dakota Gold Announces Offering of Common Stock

Lead, South Dakota--(Newsfile Corp. - February 9, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") today announced the launch of a $75,000,000 public offering of its common stock, par value $0.001 (the "Common Stock"), in the United States ( the "Offering").The Company expects to use the net proceeds of the Offering for working capital and other general corporate purposes.The shares of Common Stock will be offered by the Company with a syndicate of underwriters, led by BMO Capital Markets and Scotiabank (collectively, the "Underwriters").Dakota Gold intends to grant the Underwriters an option, exercisable for a period of 30 days from the date hereof, to purchase up to an

2/9/26 4:03:00 PM ET

Metal Mining

Basic Materials

$ASRV
$DC
$GRTX
Financials

Live finance-specific insights

AMERISERV FINANCIAL REPORTS INCREASED EARNINGS FOR THE FOURTH QUARTER AND FULL YEAR OF 2025 AND ANNOUNCES QUARTERLY COMMON STOCK CASH DIVIDEND

JOHNSTOWN, Pa., Jan. 20, 2026 /PRNewswire/ -- AmeriServ Financial, Inc. (NASDAQ:ASRV) reported fourth quarter 2025 net income of $1,442,000, or $0.09 per diluted common share. This earnings performance represented a $553,000, or 62.2%, improvement from the fourth quarter of 2024 when net income totaled $889,000, or $0.05 per diluted common share. For the year ended December 31, 2025, the Company reported net income of $5,612,000, or $0.34 per diluted common share. This represented a 61.9% increase in earnings per share from the full year 2024 when net income totaled $3,601,000, or $0.21 per diluted common share. The following table details the Company's financial performance for the three- a

1/20/26 8:00:00 AM ET

Major Banks

Finance

AmeriServ Financial Strengthens Strategic Partnership with SB Value Partners

JOHNSTOWN, Pa., Jan. 7, 2026 /PRNewswire/ -- AmeriServ Financial, Inc. (NASDAQ:ASRV) ("AmeriServ" or the "Company") and SB Value Partners, L.P. ("SBV") today announced that they entered into an agreement that amends and restates the previously executed and disclosed April 2025 consulting agreement between the parties. The amended agreement expands the nature and scope of the consulting services to be provided to the Company by SBV over the four-year term of the agreement. The amended agreement is intended to strengthen and expand the strategic partnership with SBV and results from the highly professional and excellent collaboration between both firms over the past eight months. "SBV is excit

1/7/26 9:00:00 AM ET

Major Banks

Finance

AMERISERV FINANCIAL REPORTS INCREASED EARNINGS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2025 AND ANNOUNCES QUARTERLY COMMON STOCK CASH DIVIDEND

JOHNSTOWN, Pa., Oct. 21, 2025 /PRNewswire/ -- AmeriServ Financial, Inc. (NASDAQ:ASRV) reported third quarter 2025 net income of $2,544,000, or $0.15 per diluted common share. This earnings performance represented a $1,361,000, or 115.0%, improvement from the third quarter of 2024 when net income totaled $1,183,000, or $0.07 per diluted common share. For the nine-month period ended September 30, 2025, the Company reported net income of $4,170,000, or $0.25 per diluted common share. This represented a 56.3% increase in earnings per share from the nine-month period of 2024 when net income totaled $2,712,000, or $0.16 per diluted common share. The following table details the Company's financial

10/21/25 8:00:00 AM ET

Major Banks

Finance